|
|
MBX Capital invests in Seed through Series B healthcare and life sciences companies. Target sectors include: Healthcare Services, Healthcare Technology, Insurance/Managed Care, Biotechnology, Pharmaceuticals, Medical Devices, Diagnostics, Research Tools, and Consumer Health. Early-stage checks are usually between $1 to $2,500,000, though with MBX's limited partners, the firm has the capacity to invest up to $30,000,000 in later stage rounds. MBX primarily invests in the United States and Canada, but is open to partnering with companies anywhere in the world.
|
